SCHEDULE: Joseph Reda Discloses 7.5% Stake in Catheter Precision

Joseph Reda has reported a 7.5% beneficial ownership stake in Catheter Precision, Inc., holding 176,674 shares of common stock.

Summary

• Joseph Reda beneficially owns 176,674 shares of Catheter Precision, Inc. Common Stock.
• This ownership represents 7.5% of the company's outstanding common stock.
• The filing is a Schedule 13G, indicating a passive investment intent.
• The percentage is calculated based on 2,357,127 shares of Common Stock outstanding as of February 11, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral disclosure, providing transparency on a significant individual ownership stake without offering insights into the company's operational performance or strategic direction.

Positives

• The filing itself, a Schedule 13G, is a routine disclosure of a passive ownership stake and does not contain information regarding the company's operational or financial positives.

Negatives

• The filing itself, a Schedule 13G, is a routine disclosure of a passive ownership stake and does not contain information regarding the company's operational or financial negatives.

Risks

• The filing does not detail company-specific operational or financial risks.
• Joseph Reda certified that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, mitigating potential activist investor risk from this specific shareholder.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard disclosures for passive investors who acquire more than 5% of a company's outstanding shares. This filing indicates a significant individual ownership stake in Catheter Precision, a company whose name suggests operations within the medical device industry, specifically related to catheters or precision medical instruments.

Stakeholder Impact

• Shareholders: Provides increased transparency regarding a significant individual ownership position in the company.

Key Dates

Keywords

Catheter Precision, Joseph Reda, Schedule 13G, Common Stock, Beneficial Ownership, SEC Filing, Medical Devices